U.S. Supreme Court Denies Petition for Review of ​‘Original Source’ Ruling

U.S. Supreme Court Denies Petition
For Review of ​‘Original Source’ Ruling

A federal appeals court decision that allowed a False Claims Act qui tam action alleging a drug company gave illegal kickbacks to induce providers to prescribe Procrit will not be reviewed, the U.S. Supreme Court said June 21 (Ortho Biotech Products LP v. United States ex rel. Duxbury, U.S., No. 09-654, review denied 6/21/10).